Exhibit 99.1 Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results ◦ Revenue of $277.0 Million in Q4 and$1,125.4 Million in Fiscal 2024 ◦ Solid Consumption Trends in Q4 Offset by Near-Term Supply Chain Constraints ◦ Achieved Leverage Ratio of 2.8x at Year-End, Below Long-Term Target ◦ Board of Directors Authorize New $300 Million Share Repurchase Program ◦ Initial Full-Year Fiscal 2025 Organic Revenue Growth and EPS Outlook of Approximately 1$4.40 to $4.46, respectively TARRYTOWN, N.Y.-- ...